Skip to main content
Clinical Trials/JPRN-UMIN000016518
JPRN-UMIN000016518
Not yet recruiting
未知

A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancer - A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancer

Meiwa Hospital0 sites60 target enrollmentApril 1, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Meiwa Hospital
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Previous history of severe drug\-induced allergy 2\.Multiple malignancies to be treated or synchronous colorectal cancer 3\. Active infections 4\. Serious complications 5\.Previous history of Interstitial Pneumonitis 6\.Pleural effusion or ascites requiring treatment. 7\. Active digestive tract bleeding 8\. Severe watery diarrhea 9\. Pregnant or nursing 10\.Systemic administration of corticosteroids 11\. Patients of hepatitis B virus suface antigen positivity 12\.Contraindication of S\-1or CPT\-11 13\. Patients judged inappropriate for this study by the physicians

Outcomes

Primary Outcomes

Not specified

Similar Trials